NIMUMAC (D) TABLETS

Each uncoated tablet contains:

DESCRIPTION::

Nimumac dispersible tablets contain Nimesulide which is an antipyretic & analgesic.

Nimesulide is an inhibitor of cyclooxygenase so it inhibits the synthesis of destructive prostaglandins and spares cytoprotective prostaglandins. Nimesulide appears to exert its effects also through a variety of other mechanisms and involves interference with the production action of mediators other than prostaglandins such as enzymes, toxic oxygen derivatives, cytokines, platelet-activating factors and histamine.

Pain, sprains, dental pain, post-surgical pain.

Nausea, epigastric pain, vomiting, diarrhoea, heartburn, dizziness and skin rashes.

Hypersensitivity, active peptic ulcer disease, asthma, moderate to severe hepatic impairment.

Use of Nimesulide should ordinarily be restricted to 10 days. If longer clinical use is warranted, liver function tests should be assessed periodically.

As directed by the physician.